Microbial Robotics is a global biotechnology firm.
Using open platforms, we rapidly prototype synthetic biology-based bacterial (BactoBots), viral (ViruBots), and antibiotic technologies. These MicrobialBot products are also openly available to other researchers as well as industrial water, chemical, and pharmaceutical customers.
MicrobialBots can perform functions such as induce biomarker expression by cancer cells, kill cancer cells, kill pathogens, produce chemicals, and build materials.
An Open Therapeutics™ model enables scientists and researchers to adopt our open synthetic biology platforms. These platforms enable collaborators to develop chemical, therapeutic, and water applications.
MicrobialBots can be protected by a Genetics Rights Management (GeRM™) consumable powder system. Instead of trying to ship genetically modified organisms (GMO) across borders, GeRM enables adopters to decentralize manufacturing and distribution of BactoBots and ViruBots. GeRM, as a consumable powder, creates a recurring revenue model.
Proteome Platform™ is a joint effort with Bacmine SL. Initially, this platform is focused on finding essential proteins required for pathogen survival. Discovered proteins can be targeted by researchers to develop therapeutic agents that will kill the pathogens, including antibiotic resistant organisms. Our efforts include locating potential antibiotic targets for methicillin-resistant MRSA and multi-drug resistant tuberculosis (MDR-TB).
If you are an Innovator, Researcher, or Organization, contact us today. We can help you move significant science forward, generate publications, and improve the global industrial ecosystem.